Connealy Pamela Yanchik Health Sciences Acquisitions Corp 2 (HSAQ) insider trading activity

Connealy Pamela Yanchik is Director of Health Sciences Acquisitions Corp 2. Currently has a direct ownership of 21,289 shares of HSAQ, which is worth approximately $0. The most recent transaction as insider was on Jun 20, 2024, when has been sold 5,376 shares (Common Stock, par value $0.0001 per share ("Common Stock")) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 21.3K

0% 3M change

33.78% 12M change

Total Value Held $0

Connealy Pamela Yanchik Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 20 2024	BUY Grant, award, or other acquisition	-	5,376 Added 20.16%	21,289 Common Stock, par valu...
Jul 20 2023	BUY Grant, award, or other acquisition	-	11,667 Added 42.3%	15,913 Common Stock, par valu...
Apr 12 2023	BUY Exercise of conversion of derivative security	-	758 Added 15.15%	4,246 Common Stock, par valu...
Jan 26 2023	BUY Grant, award, or other acquisition	-	3,488 Added 50.0%	3,488 Common Stock, par valu...

Also insider at

IMVT

Immunovant, Inc. Healthcare

Chief Financial Officer

PYXS

Pyxis Oncology, Inc. Healthcare

CFO & COO

CPY